EyePoint Pharmaceuticals Inc. buy Mizuho
Start price
17.02.24
/
50%
€26.60
Target price
17.02.25
€36.18
Performance (%)
-74.48%
End price
18.02.25
€6.79
Summary
This prediction ended on 18.02.25 with a price of €6.79. Massive losses of -74.48% were the result for the BUY prediction by Mizuho. Mizuho has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 9.339% | 9.339% | 85.190% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Mizuho for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target raised by analysts at Mizuho from $30.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten
Current prediction by Mizuho for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.49
16.05.25
16.05.25
€23.21
16.05.26
16.05.26
166.56%
17.12.25
17.12.25
Stopped prediction by Mizuho for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
-45.28%
08.05.25
08.05.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.70
07.12.23
07.12.23
€27.74
07.12.24
07.12.24
-58.38%
08.12.24
08.12.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.00
02.11.23
02.11.23
€18.78
02.11.24
02.11.24
56.50%
03.11.24
03.11.24